Paper-Based Platform with an In Situ Molecularly Imprinted Polymer for β-Amyloid
- 15 May 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 5 (21) , 12057-12066
Abstract
Alzheimer’s disease (AD) is one of the most common forms of dementia affecting millions of people worldwide. Currently, an easy and effective form of diagnosis is missing, which significantly hinders a possible improvement of the patient’s quality of life. In this context, biosensors emerge as a future solution, opening the doors for preventive medicine and allowing the premature diagnosis of numerous pathologies. This work presents a pioneering biosensor that combines a bottom-up design approach using paper as a platform for the electrochemical recognition of peptide amyloid β-42 (Aβ-42), a biomarker for AD present in blood, associated with visible differences in the brain tissue and responsible for the formation of senile plaques. The sensor layer relies on a molecularly imprinted polymer as a biorecognition element, created on the carbon ink electrode’s surface by electropolymerizing a mixture of the target analyte (Aβ-42) and a monomer (O-phenylenediamine) at neutral pH 7.2. Next, the template molecule was removed from the polymeric network by enzymatic and acidic treatments. The vacant sites so obtained preserved the shape of the imprinted protein and were able to rebind the target analyte. Morphological and chemical analyses were performed in order to control the surface modification of the materials. The analytical performance of the biosensor was evaluated by an electroanalytical technique, namely, square wave voltammetry. For this purpose, the analytical response of the biosensor was tested with standard solutions ranging from 0.1 ng/mL to 1 μg/mL of Aβ-42. The linear response of the biosensor went down to 0.1 ng/mL. Overall, the developed biosensor offered numerous benefits, such as simplicity, low cost, reproducibility, fast response, and repeatability less than 10%. All together, these features may have a strong impact in the early detection of AD.Keywords
Funding Information
- European Regional Development Fund (POCI-01-0145-FEDER-007688, POCI-01-0145-FEDER-016637, POCTEP/0245-BEROS-1-E, PTDC/AAG-TEC/5400/2014, UID/CTM/50025/2019)
- Fundação para a Ciência e a Tecnologia (POCI-01-0145-FEDER-007688, POCI-01-0145-FEDER-016637, POCTEP/0245-BEROS-1-E, PTDC/AAG-TEC/5400/2014, SFRH/BD/115173/2016, SFRH/BPD/97891/2013, UID/CTM/50025/2019)
This publication has 59 references indexed in Scilit:
- A carbon nanotube metal semiconductor field effect transistor-based biosensor for detection of amyloid-beta in human serumBiosensors and Bioelectronics, 2013
- Surface Plasmon Resonance Imaging of Amyloid-β Aggregation Kinetics in the Presence of Epigallocatechin Gallate and MetalsAnalytical Chemistry, 2012
- Microbiosensor for Alzheimer’s disease diagnostics: detection of amyloid beta biomarkersJournal of Neurochemistry, 2012
- Tuning the electronic transport properties of graphene through functionalisation with fluorineDiscover Nano, 2011
- Paper ElectronicsAdvanced Materials, 2011
- Electronic Structures and Structural Evolution of Hydrogenated Graphene Probed by Raman SpectroscopyThe Journal of Physical Chemistry C, 2011
- Enzyme entrapment by β-cyclodextrin electropolymerization onto a carbon nanotubes-modified screen-printed electrodeBiosensors and Bioelectronics, 2010
- Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptideBiomaterials, 2010
- A Rapid Label-Free Electrochemical Detection and Kinetic Study of Alzheimer's Amyloid Beta AggregationJournal of the American Chemical Society, 2005
- Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in JapanAnnals of Neurology, 1998